Optimizing IR-1061 Liposomes for High-Resolution NIR-II Imag
2026-05-07
Optimizing IR-1061 Liposomes for High-Resolution NIR-II Imaging
Study Background and Research Question
Fluorescence imaging (FI) has become a cornerstone technique in biomedical research, enabling sensitive, non-radioactive detection for applications such as DNA sequencing, immunoassays, and live cell imaging (paper). In particular, the near-infrared II (NIR-II, 1000–1700 nm) region has garnered attention for its reduced photon scattering and background autofluorescence, making it especially promising for deep tissue and intravital imaging. However, the development of organic small-molecule fluorophores that combine high brightness, photostability, and biocompatibility remains a challenge, as does their effective encapsulation for in vivo delivery. The study by Yu et al. addresses the central question: how do liposomal formulation parameters—specifically, the charge of phospholipid carriers and the concentration state of the NIR-II dye IR-1061—influence fluorescence performance and imaging utility in living systems (paper)?Key Innovation from the Reference Study
The primary innovation lies in the rational engineering of a NIR-II fluorescent nanosystem based on IR-1061, a hydrophobic cyanine dye with peak emission at 1064 nm and a quantum yield (QY) of ~1.7%—substantially higher than typical carbon nanotubes and many other cyanine dyes (paper). By systematically varying the liposomal phospholipid charge (anionic, neutral, cationic) and the dye loading, the authors uncover how these factors modulate encapsulation efficiency, dye aggregation, and resultant fluorescence performance. The optimized system—an anionic liposome formulation (IR1061-ALP-N3)—achieves both enhanced fluorescence output and prolonged circulation, enabling high-resolution angiography for over 16 hours in vivo (paper).Methods and Experimental Design Insights
The research team designed and synthesized IR-1061-loaded liposomes using phospholipids with varying charges. Experimental groups included cationic, neutral, and anionic liposomes, each encapsulating different concentrations of IR-1061 to probe aggregation effects. The following key methodological aspects are notable:- Systematic encapsulation efficiency measurements and fluorescence quantification for each liposome type.
- Analysis of the physical state of IR-1061 (free vs. aggregate) within liposomes as a function of loading concentration.
- In vivo fluorescence imaging (FI) in mice, with assessment of vascular imaging clarity and duration.
- Comparative evaluation of photostability and circulation time in physiological conditions.
Protocol Parameters
- assay | emission peak | 1064 nm | optimal for deep tissue NIR-II imaging | enables reduced scattering and high-contrast in vivo visualization | paper
- assay | quantum yield (QY) | ~1.7% | suitable for vascular and tissue imaging | higher than many conventional NIR-II organic dyes | paper
- assay | liposome charge | anionic > neutral > cationic (encapsulation efficiency ranking) | best performance with anionic phospholipids | stronger electrostatic compatibility with IR-1061 | paper
- assay | circulation time | >16 hours | supports long-term angiography | prolonged vascular retention enhances imaging window | paper
- workflow_recommendation | dye preparation solvent | DMSO (≥25.65 mg/mL), not ethanol/water | ensures solubility and functional encapsulation | product_spec
- workflow_recommendation | storage conditions | -20°C, desiccated, avoid long-term solutions | maintains dye integrity for experimental use | product_spec
Core Findings and Why They Matter
The study elucidates several critical phenomena:- Phospholipid charge dictates encapsulation: Anionic liposomes encapsulate IR-1061 most effectively, while cationic liposomes perform worst, corresponding to the underlying electrostatic interactions between dye and carrier (paper).
- Dye concentration state modulates fluorescence: IR-1061 exists in two forms within liposomes: free (highly fluorescent) at optimal concentrations, and aggregated (quenched fluorescence) at high loadings. Excessive loading triggers aggregation and reduces signal intensity.
- High-resolution, long-term vascular imaging: The optimized IR1061-ALP-N3 system enables clear systemic angiography in mice with significant spatial resolution and persistent fluorescence for over 16 hours (paper).
- Biocompatibility and clinical translation potential: Compared to inorganic NIR-II materials (e.g., quantum dots, rare earth nanoparticles), organic fluorophores like IR-1061 offer faster excretion and reduced long-term tissue retention, mitigating safety concerns (paper).
Comparison with Existing Internal Articles
Recent internal reports reinforce and contextualize these findings:- The article "IR-1061: Near Infrared Fluorescent Dye for In Vivo Imaging" highlights the practical workflow advantages of IR-1061, emphasizing its robust signal and low autofluorescence for tissue and vascular imaging. This aligns with the reference paper’s demonstration of enhanced clarity and signal duration using optimized liposomal formulations.
- Polymer encapsulation strategies, such as those discussed in "Polymer Chirality Modulates IR-1061 Encapsulation for Deep Imaging", echo the importance of carrier–dye interactions in maximizing fluorescence performance. Both studies converge on the principle that nanoenvironment design—whether via liposomes or chiral polymers—directly impacts IR-1061’s utility as a fluorescent dye for biomedical research.
- For cancer-targeted imaging and therapy, reports like "Ultrasound-Enhanced Cu Single-Atom MOFs for Targeted Nanocatalytic Cancer Therapy" utilize IR-1061 for tracking and targeting, further validating the dye’s versatility in multiple in vivo molecular imaging contexts.
Limitations and Transferability
Despite the demonstrated promise, several considerations remain:- Aggregation limits dye loading: High concentrations of IR-1061 in confined liposomal spaces promote aggregation and fluorescence quenching. This necessitates careful optimization for each application (paper).
- Carrier specificity: The findings are specific to phospholipid-based liposomes; transferability to other nanocarriers (e.g., polymeric micelles, inorganic nanoparticles) requires validation (paper).
- In vivo complexity: Although murine models demonstrate long-circulating imaging, translation to human or other large animal models may introduce pharmacokinetic and immunological variables yet to be fully addressed.
- Solubility constraints: IR-1061 is insoluble in ethanol and water, restricting preparation protocols to compatible solvents such as DMSO (workflow_recommendation; product_spec).